Patent Assignment
Reel/Frame 062486/0654
Assignment of Assignor's Interest
Recorded: 2023-01-25
Pages: 8
Assignor
CADENT THERAPEUTICS, INC.
Executed: 2022-12-01
Assignee
NOVARTIS AG
LICHTSTRASSE 35, BASEL, 4056, SWITZERLAND
Covered Properties
(5)
Selective Octahydro-Cyclopenta[C] Pyrrole Negative Modulators of NR2B
Selective Octahydro-Cyclopenta[C] Pyrrole Negative Modulators of NR2B
Selective Octahydro-Cyclopenta[C]Pyrrole Negative Modulators of NR2B
Selective Octahydro-Cyclopenta[C]Pyrrole Negative Modulators of NR2B
Selective Octahydro-Cyclopenta[C] Pyrrole Modulators of NR2B
Application:
61/883,050 →
Related Assignments
(9)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 1, 2014
From: ANDERSON, DAVID R.; VOLKMANN, ROBERT A.; MENNITI, FRANK S.
To: MNEMOSYNE PHARMACEUTICALS, INC.
Reel/Frame 032575/0849 →
Assignment of Assignor's Interest
Jan 29, 2015
From: ANDERSON, DAVID R.; VOLKMANN, ROBERT A.
To: MNEMOSYNE PHARMACEUTICALS, INC.
Reel/Frame 034842/0128 →
Change of Name
Oct 5, 2016
From: MNEMOSYNE PHARMACEUTICALS, INC.
To: LUC THERAPEUTICS, INC.
Reel/Frame 040236/0496 →
Change of Name
Jan 5, 2018
From: LUC THERAPEUTICS, INC.
To: CADENT THERAPEUTICS, INC.
Reel/Frame 045012/0344 →
Change of Name
Mar 16, 2022
From: LUC THERAPEUTICS, INC.
To: CADENT THERAPEUTICS, INC.
Reel/Frame 059369/0256 →
Change of Name
Mar 16, 2022
From: MNEMOSYNE PHARMACEUTICALS, INC.
To: LUC THERAPEUTICS, INC.
Reel/Frame 059369/0242 →
Assignment of Assignor's Interest
Mar 16, 2022
From: ANDERSON, DAVID R.; VOLKMANN, ROBERT A.; MENNITI, FRANK S.
To: MNEMOSYNE PHARMACEUTICALS, INC.
Reel/Frame 059369/0246 →
Change of Name
Jan 25, 2023
From: MNEMOSYNE PHARMACEUTICALS, INC.
To: LUC THERAPEUTICS, INC
Reel/Frame 062511/0597 →
Change of Name
Jan 25, 2023
From: LUC THERAPEUTICS, INC.
To: CADENT THERAPEUTICS, INC.
Reel/Frame 062511/0710 →